AbbVie and Google parent company Alphabet are each committing $500 million to continue funding the scientists researching aging at the ambitious Alphabet unit called Calico, the two companies announced Tuesday morning.

The extension of the collaboration between AbbVie and Calico, begun in 2014, brings Calico’s total funding to $2.5 billion. Calico wouldn’t say how much of that cash it’s burned through since it was launched in 2013.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy